It is known that the urokinase plasminogen activator (uPA) is a serine proteinase that increases the amount of plasmin generated by plasminogen, thereby disrupting the extracellular matrix (ECM) and promoting cancer invasion and migration [45]. The gene discussed is PLAU; the disease is cancer.